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A B S T R A C T
Chronic kidney disease (CKD) progression results in musculoskeletal dysfunction that is associated with a higher
likelihood of hospitalization and is predictive of hospitalizations and mortality. Despite this, there is a lack of
effective interventions to treat the musculoskeletal dysfunction. We studied treadmill running as an intervention
to improve musculoskeletal health in a translational rat model that has slowly progressive CKD. CKD rats were
subjected to treadmill exercise or no treadmill exercise for 10 weeks (n=8 each group). Animals ran for 60min,
5 times per week starting at a speed of 8m/min and ending at 18m/min (1m/min increase/week). Treadmill
training had no effect on muscle strength (assessed as maximally stimulated torque), half-relaxation time (time
from peak torque to 50%) or muscle cross-sectional area. Overall, there were no biochemical improvements
related to CKD progression. Skeletal muscle catabolism was higher than non-exercised animals without a con-
comitant change in muscle synthesis markers or regeneration transcription factors. These results suggest that
aerobic exercise, achieved via treadmill running was not protective in CKD animals and actually produced
potentially harmful effects (increased catabolism). Given the high prevalence and dramatic musculoskeletal
mobility impairment in patients with CKD, there is a clear need to understand how to effectively prescribe
exercise in order to benefit the musculoskeletal system.
1. Introduction
Chronic kidney disease (CKD) is common in the United States, af-
fecting> 30 million adults [1]. Chronic kidney disease progression is
associated with muscle atrophy, reduced strength and impaired mobi-
lity; known as sarcopenia or frailty [2–4]. The progressive loss of
muscle size and function leads to impaired physical function that is
associated with a higher likelihood of being hospitalized [5] and is
predictive of mortality in patients with CKD and those on dialysis [6,7].
Despite this, there is a lack of effective interventions to treat the mus-
culoskeletal dysfunction.
Exercise is often viewed as a primary intervention to aide in mus-
culoskeletal health. In persons with chronic disease conditions, exercise
participation leads to a number of beneficial effects [8]. In CKD, a
systematic review of clinical exercise studies for patients with stage 2–5
CKD, demonstrated beneficial effects on aerobic capacity and blood
pressure, but no difference in muscle size, strength, or walking capacity
[9]. In general, the extent to which exercise is beneficial for patients
with CKD is inconclusive. Similarly, animal models of forced exercise
have shown inconclusive evidence on the beneficial effects of exercise
[10–14]. These animal studies mimic what is seen clinically with no
effect on disease progression [10,13] or muscle protein synthesis
[10,14], and mixed effects on antioxidants [13,15]. This lack of effect
may be due to a number of factors surrounding the exercise prescrip-
tion, mode, and disease model. We therefore intended to study the ef-
fects of aerobic exercise in a translational rat model with slowly pro-
gressive CKD with demonstrated muscle dysfunction [16,17]; to
identify the effects of 10 weeks of treadmill aerobic exercise on skeletal
muscle properties.
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We used a rat model of CKD (Cy/+ rats) that develops progressive
azotemia with terminal uremia by 40 weeks [18]. Animals were fed a
casein diet (Purina AIN-76A, Purina Animal Nutrition, Shreveport, LA,
USA; 0.53% Ca and 0.56% P) beginning at 24 weeks (approximately
50% normal kidney function) in order to promote consistent disease
development. At 25 weeks, CKD rats were subjected to treadmill ex-
ercise or no treadmill exercise for 10 weeks (n= 8 each group). Ani-
mals ran for 60min, 5× /week starting at a speed of 8m/min and
ending at 18m/min (1m/min increase/week). Animals were accli-
mated for one week prior to initiation of training bout (from weeks
24–25). Animals received a mild electrical stimulus when failing to
maintain prescribed speed and an individual treadmill session was
terminated if electrical stimulation was given more than 3 times in one
minute, or if the animal sat on the coils for greater than 10 s. The In-
diana University School of Medicine Institutional Animal Care and Use
Committee reviewed and approved all procedures prior to initiating the
study.
2.2. Electrically stimulated torque
Prior to euthanasia at 35 weeks, muscle strength/torque was as-
sessed (1305 A Whole Rat Test System, Aurora Scientific Inc., Aurora,
ON, Canada). Animals were placed in a supine position and their right
foot secured to a foot pedal attached to a servomotor [17]. Electrodes
were placed near the common peroneal nerve to stimulate a dorsi-
flexion twitch response and input current was adjusted to achieve
maximum twitch response followed by a 20% increase to ensure su-
pramaximal stimulation of muscle fibers (~15mA for dorsiflexion).
Maximum isometric torque (N·m) was recorded for various stimulation
frequencies ranging between 10 Hz and 200 Hz, with a pulse width of
0.2 ms and pulse duration of 200ms. Following testing, time to max-
imum torque and half relaxation time were calculated from the peak
isometric torque data.
2.3. Tissue procurement
Blood was collected prior to euthanasia, and the extensor digitorum
longus (EDL) from the non-stimulated limb was collected. The middle
third of EDL was isolated, placed in OCT media and frozen in liquid
nitrogen chilled isopentane; then remaining tissue was snap frozen in
liquid nitrogen. The remaining EDL was stored for protein and RNA
analysis at −80 °C.
2.4. Assays
Blood plasma was analyzed for blood urea nitrogen (BUN), calcium
and phosphorus using colorimetric assays (BioAssay Systems, Hayward,
CA, USA) and intact PTH by ELISA (Alpco, Salem, NH, USA).
2.5. Muscle cross-sectional area
Immunostaining was performed on frozen EDL cryosections.
Sections were incubated overnight with a polyclonal anti-laminin an-
tibody (Sigma, St. Louis, MO) in order to label muscle fiber perimeters
for measurement of fiber cross-sectional area. Skeletal muscle cross-
sections were imaged at 10x magnification using a Spot RT Color
Camera System mounted on an inverted Nikon Diaphot 200 microscope
(Nikon Instruments Inc, Melville, NY), 3 images per Section, 3 sections
per animals were analyzed. Prior to analysis, each image was inspected
for sectioning artifacts, blood vessels, or poor image quality, and any
sections that were not acceptable were omitted from the analysis.
Muscle fiber cross-sectional area was measured with an automated,
custom-written macro in ImageJ (NIH, Bethesda, MD), provided by Drs.
Rick Lieber and Samuel Ward [19].
2.6. RNA isolation and real time PCR
Total RNA was isolated using miRNeasy Mini Kit (Qiagen) as pre-
viously described [16]. Gene expression was determined by real time
PCR using TaqMan mRNA assays (Applied Biosystems, Foster City, CA).
Target-specific PCR primers (Pax-7, MyoD, Myostatin, Myogenin,
Atrogin 1, IGF-1) were obtained from Applied Biosystems. The cycle
number at which the amplification plot crosses the threshold was cal-
culated (CT), and the ΔΔCT method was used to analyze the relative
changes in gene expression and normalized by β-actin.
2.7. Western blot
Western blotting was performed as previously described [16,20].
Briefly, the EDL muscle was homogenized and the total protein lysates
analyzed for expression of markers for protein degradation using anti-
body against Ubiquitin and p70 (total and phosphorylated), respec-
tively (1:500, Santa Cruz Biotechnology, Santa Cruz, CA). The blots
were incubated overnight at 4 oC followed by incubating with perox-
idase conjugated secondary antibody (1:5000 dilution) and im-
munodetection assessed with the Enhanced Chemiluminescence Prime
Western Blot Detection Reagent (Amersham, Piscataway, NJ). Band
intensity was analyzed by ChemiDoc MP Imaging System (Imaging Lab
4.0, Bio-Rad, Richmond, CA) and normalized to total protein expression
using Ponceau S (Santa Cruz Biotechnology, Santa Cruz, CA) or phos-
phorylated to total p70 were utilized as the normalization for p70 ex-
pression.
2.8. Statistics
Two-tailed independent sample t-tests were used to compare means
between CKD and CKD +exercise. Data are presented as mean± SD.
3. Results
At 35 weeks of age (approximately 15% of normal kidney function),
there was no difference between groups for muscle strength (via
maximally stimulated torque; Fig. 1A) or half-relaxation time (time
from peak torque to 50% torque reduction; Fig. 1B). There was also no
difference in muscle fiber cross-sectional area between CKD rats
(2821 µm ± 405) and CKD+exercise (2413 µm± 449). Biochemical
measures, indicative of disease severity were not significantly different
between groups (Table 1) with the exception of elevations in Ca++
with exercise. Similarly, there was no difference in body mass.
In an attempt to better understand the lack of efficacy of treadmill
running, we examined muscle protein turnover. Treadmill exercise did
not alter the gene expression of IGF-1, an upstream, global marker for
protein synthesis (Fig. 2A) or its downstream target p70 (Fig. 2B).
However, treadmill exercise increased muscle catabolism, with levels of
ubiquitin protein expression 50% higher compared to non-exercised
animals (Fig. 3A). The propensity towards catabolism was also corro-
borated by higher gene expression levels of the ubiquitin pathway gene
atrogin-1 (Fig. 3B, p < 0.05).
To determine if skeletal muscle regeneration was altered, we mea-
sured RNA transcription factors associated with muscle stem cell re-
generation. Treadmill exercise resulted in 44% lower expression of the
muscle stem cell quiescence marker PAX7 (Fig. 4, p < 0.05), but there
was no difference in expression of the regenerative factors myoD or
myogenin (Fig. 4).
4. Discussion
Exercise has demonstrated beneficial effects in a number of chronic
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disease conditions [21], but in CKD the data are conflicting and most
often reveal muted responses [9]. In this study, we hypothesized that
aerobic exercise (i.e. treadmill exercise) would improve skeletal muscle
properties. Overall, we did not find a positive effect from aerobic ex-
ercise in improving muscle performance (i.e. maximally stimulated
torque) or cross-sectional area. In fact, we found increased skeletal
muscle catabolism based on increased atrogin-1 and ubiquitination,
without concomitant protein synthesis. There was also reduction in
PAX-7 expression, a marker of muscle satellite stem cell quiescence.
Reduced quiescence indicates muscle stem cell activation that could be
deemed inappropriate or ineffective as there was no further down-
stream alterations in myogenin or myoD. These results suggest that our
exercise protocol was not effective in rats with CKD due to increased
catabolism without concomitant and/or impaired satellite cell differ-
entiation and downstream regeneration in CKD.
The lack of exercise efficacy demonstrated in this slowly progressive
CKD model is similar to results from other CKD animal models. Yoshida
et al. (2017) aerobically exercised rats at 15m/min for 1 h/day, 5 days/
wk for 7 weeks, waiting 5 weeks after 5/6 nephrectomy. Although they
additionally compared low protein diet vs a branched-chain amino
acids diet, the study found that treadmill exercise in CKD rats did not
have a positive effect irrespective of the diet upon skeletal muscle cross-
sectional area. Further, they found no effect on skeletal muscle protein
synthesis or degradation. De Souza et al. performed a one step 5/6
nephrectomy in rats, followed by a forced exercise intervention of
treadmill training at 17m/min for 50min/day for 8 weeks. They found
beneficial anti-oxidant effects (increased superoxide production and
reduced oxidative damage) but there were no assessments of muscle
cross-sectional area or function. Moningka et al., 2011, examined age-
related kidney disease using Fisher 344 male rats; these rats performed
treadmill exercise at 15m/min, 15° incline for 60min/day for 10–12
weeks. They found that exercise did not mitigate age-related kidney
changes, nor alter protective antioxidant enzymes and oxidative stress.
In the present study, we not only assessed morphologic and gene
changes, but also function as a surrogate for clinically meaningful im-
provements in physical performance.
The limited response to treadmill training in our study and other
studies in rat models may be due to a number of factors including
dysfunction of stem cell differentiation as shown in our study, and in-
creased catabolic state as shown in the present study and by Wang
et al., 2009. Uremic toxins may have direct effects on metabolic path-
ways, and impaired cardiovascular function may alter blood flow with
intensive exercise. Another possibility is the behavioral stress related to
this type of forced exercise. Treadmill training in animals is similar to
humans, occurring over a motorized belt. However, the animals are
performing exercise during the day, opposite of their normal awake
cycle. Further, the studies require increased human handling, exercise
in a non-familiar small compartment, and the animals experience an
electrical stimulus when unable to maintain the prescribed speed. These
additional factors may result in detrimental behavioral stress [22]. One
limitation to our study is that we did not have a normal control group,
thus we cannot fully determine if the observed response is unique to
CKD or to the exercise regimen itself.
Fig. 1. The effect of treadmill training on skeletal muscle function in CKD.
Table 1
End-point biochemical properties.
Group Body mass (g) BUN (mg/dl) Calcium (mg/dl) Phosphorus (mg/dl) PTH (pg/dl)
CKD 534 ± 43 58 ± 9 7.05 ± 1.70 12.3 ± 3.1 1375 ± 504
CKD+Ex 524 ± 7 55 ± 4 9.69 ± 2.26* 10.7 ± 1.2 1333 ± 284
Mean ± SD.
* p < 0.05 for difference from CKD.
Fig. 2. The effect of treadmill training on skeletal muscle function in CKD.
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Given the similarity of the rodent models examined to date and the
lack of consistent positive effects, there is mounting support that
aerobic exercise is ineffective in CKD. However, an alternative hy-
pothesis is that CKD, with its systemic comorbidities and baseline mo-
bility impairment [23], requires a different approach to exercise. In
humans, exercise in chronic disease rehabilitation programs is initiated
slowly and prescribed under supervision of trained professionals. A
properly prescribed and dosed exercise in rats might therefore be ef-
fective if there is first an assessment of maximal aerobic capacity (using
VO2max), and then an appropriate scaling of exercise intensity. These
working intensities determine the treadmill training speeds. This lack of
prescription specificity and graded increase may also partially explain
the results from the present, and other studies, in rodents. Supporting
this, studies using voluntary wheel running in rats with CKD have de-
monstrated beneficial effects anti-inflammatory signaling and cardiac
function [24–27] although musculoskeletal outcomes were not as-
sessed. Further studies comparing wheel versus treadmill training
would demonstrate preferential interventions of increased physical
activity versus intensive exercise. Given the high prevalence and dra-
matic musculoskeletal mobility impairment in patients with CKD, there
is a clear need to understand how to effectively prescribe exercise in
order to benefit the musculoskeletal system.
There was no significant difference between the groups when
assessing in vivo dorsiflexion maximum isometric torque (A) or half
relaxation time (B). Data are shown for CKD (white bars) rats and
CKD+exercise (black bars) at 35 weeks of age. Values are mean± SD.
IGF-1 is an upstream, global marker for protein synthesis. (A) There
was no difference in IGF-1 expression in the EDL of 35 week old CKD
rats and CKD+ exercise, as determine by qRT-PCR. Protein synthesis
was further assessed for IGF-I downstream target p70; (B) the ratio
between total and phosphorylated p70 are shown. There was no dif-
ference between the two groups CKD (white bars) and CKD+exercise
(black bars). Data are shown as mean± SD.
(A) Protein expression for total ubiquitination by western blot in
skeletal muscle was greater in the CKD animals that were exercised. (B)
Atrogin-1 expression RNA expression was also higher in the EDL of 35
week old rats that were exercised compared to CKD without exercise.
Data are shown as mean± SD. *P < 0.05, CKD (white bars) vs.
CKD+exercise (black bars).
The expression of myogenic factors was determined by qRT-PCR in
the EDL muscle from 35 weeks old chronic kidney disease (CKD); white
bars and CKD+exercise (black bars) rats. In the CKD+exercise group
there is increased satellite (stem cell) activation due to lower expression
of Pax-7, but no difference in downstream myogenic markers MyoD and
myogenin expression. These data suggest blockade of normal re-
generative response to exercise. Data are shown as mean± SD.
*P < 0.05, CKD vs. CKD+ exercise.
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Fig. 3. Proteolytic pathways in muscle are activated by treadmill training in CKD.
Fig. 4. Skeletal muscle regeneration is altered with treadmill training in CKD.
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